Category: Access campaign
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
As WHO issues critical new TB treatment recommendations, MSF calls on governments to urgently scale-up all oral treatment
Access to medicines: HIV and TB treatment at risk as countries gradually lose Global Fund support
Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day
MSF warns high prices of tuberculosis drugs restrict people´s access to best drug-resistant TB treatment
MSF response to first-ever UN tuberculosis summit
Global leaders must make bold commitments at first-ever UN tuberculosis summit
MSF and groups call for end to Gilead’s unwarranted hepatitis C grug monopoly in Europe
MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options
